Ocular complications common after pediatric HSCT

March 1, 2013
Ocular complications common after pediatric HSCT
For pediatric patients undergoing hematopoietic stem cell transplantation, complications are common, but are generally mild and self-limiting, according to a study published online Feb. 28 in JAMA Ophthalmology.

(HealthDay)—For pediatric patients undergoing hematopoietic stem cell transplantation (HSCT), complications are common, but are generally mild and self-limiting, according to a study published online Feb. 28 in JAMA Ophthalmology.

To examine the development of ocular complications in children within one year after HSCT, Viera Kalinina Ayuso, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues conducted a prospective study of 49 children who underwent systematic ophthalmologic evaluations before HSCT; after the procedure and before leaving the HSCT unit; and at three, six, and 12 months after HSCT.

The researchers found that 27 percent of patients developed an ocular complication following HSCT, including dry eye syndrome (14 percent), (sub)retinal hemorrhage (12 percent), edema (6 percent), chorioretinal lesions (4 percent), vitritis (2 percent), and increased intraocular pressure (2 percent). With the exception of , which developed a median of five months after HSCT, the other conditions developed within three months after HSCT. The symptoms were mild and self-limiting in most cases. Compared to children with nonmalignant disease, children with malignant disease had an increased risk of development of ocular complications.

"In conclusion, ocular adverse effects in pediatric HSCT patients are common, but most are mild with no long-term visual sequelae; however, a potential risk of development of vision-threatening complications cannot be ruled out completely in this vulnerable group of patients," the authors write.

Explore further: BMI and lean body mass decline after allogeneic HSCT

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

BMI and lean body mass decline after allogeneic HSCT

October 4, 2012
(HealthDay)—In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due to a reduction in ...

Bortezomib beneficial in graft-versus-host disease prophylaxis

August 8, 2012
(HealthDay) -- Patients with hematologic malignancies undergoing an HLA-mismatched unrelated donor (MMUD) reduced-intensity conditioning (RIC) hematopoietic stem cell transplantation (HSCT) may benefit from a prophylactic, ...

Targeting histone deacetylases as a new strategy for graft versus host disease prevention

December 9, 2012
New research shows that the addition of the oral anti-cancer agent vorinostat to standard therapy given before, during, and after hematopoietic stem cell transplantation (HSCT) may safely reduce the incidence and severity ...

Recommended for you

Scientists regenerate retinal cells in mice

July 26, 2017
Scientists have successfully regenerated cells in the retina of adult mice at the University of Washington School of Medicine in Seattle.

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina

July 24, 2017
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing ...

Too little vitamin D may hinder recovery of injured corneas

July 24, 2017
Injury or disease in combination with too little vitamin D can be bad for the window to your eyes.

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.